
Izberite svojo etiketo
prikazano neposredno na vialiLaboratorijsko poročilo
PDF- Testirano
- Thymosin Alpha-1 5mg
- Laboratorij
- Analiza Białek
- Datum
- November 2026
- Rezultat
- 99% purity (5.33 mg measured)
- Endotoksini
- 4.56 EU/vial
- Št. naročila
- Geslo
Neodvisno testirano, preverljivo z geslom neposredno pri laboratoriju.
Thymosin Alpha-1
Immune System
- Laboratorijsko testirano · Čistost 99 %
- Odprema iz Nemčije
Naročilo
- DHL s sledenjem
- Diskretna embalaža
Na prvi pogled
Thymosin Alpha-1 v številkah
Ključni podatki iz našega leksikona.
Celoten vnos v leksikonu- Class
- Immune-modulating peptidethymus-derived
- Frequency
- ~2x per weekin phases
- Form
- Lyophilised powderreconstituted with BAC water
- Sizes
- 5 to 10 mg2 sizes in the shop
What studies show
The source in the lexiconRandomized controlled study of thymosin alpha-1 in severe sepsis (ETASS) (opens in a new tab)
Wu et al., Critical Care, 2013
Znanje
Vse o Thymosin Alpha-1
Podrobne informacije bodo kmalu na voljo.
Odmerjanje
Nalaganje podatkov o odmerjanju …
Priporočljivo zraven
Kaj potrebujete zraven
Bakteriostatska voda se samodejno doda v vašo košarico. Brizge in robčki z enim klikom.
Inzulinske brizge
10 kos. · 5.50 €
Alkoholni robčki
50 kos. · 10 €
Koliko vode?
Enote na brizgi za vašo velikost viale.
Odpri kalkulator →Is Thymosin Alpha-1 approved?
Yes, but not everywhere. As thymalfasin it is approved in over 35 countries according to a 2009 review, mainly for hepatitis B and C and to strengthen the immune system. There is no approval in the US, ChEMBL lists the compound at phase 3.
How does Thymosin Alpha-1 work?
In cell and mouse experiments it made dendritic cells more active, the cells that show pathogens to the immune system. This ran via the receptor TLR9. At the same time it promoted regulatory T cells, which slow down excessive reactions. ChEMBL lists no confirmed mechanism in humans.
What do the sepsis trials show?
In ETASS with 361 people 26 percent died within 28 days with Thymosin Alpha-1 and 35 percent without, a difference that just missed certainty. The larger TESTS trial with 1,106 people and placebo found 23.4 versus 24.1 percent, so no difference. A possible benefit from age 60 counts only as a hint there.
Are there data on cancer?
In a trial with 488 people with advanced melanoma Thymosin Alpha-1 was added to chemo. The highest study dose was 6.4 mg. More tumours responded and median survival was 9.4 versus 6.6 months, but not statistically certain. There were no extra side effects.
Does it help in severe pancreatitis?
Not with certainty in the TRACE trial with 508 people. Infected dead tissue occurred in 15.7 percent with Thymosin Alpha-1 and 18.1 percent on placebo. The main goal was therefore not reached.
Which side effects are known?
In TESTS 66.4 percent on Thymosin Alpha-1 and 67.6 percent on placebo had an adverse event, serious events were 26.8 versus 29.3 percent. ETASS recorded no serious side effects caused by the drug. With autoimmune disease the regular entry advises restraint.
Sorodno
Sorodni izdelki
Thymalin
Peptidi · Imunski sistem Imunski sistem
2 velikosti
= od 16 €/vialo
KPV
Peptidi · Imunski sistem Imunski sistem
4 velikosti
Laboratorijsko testirano
= od 11.6 €/vialo
VIP
Peptidi · Imunski sistem Imunski sistem
2 velikosti
= od 23.2 €/vialo
VIP Nasal
Peptidi · Imunski sistem Imunski sistem
1 velikost
Thymosin Alpha-1